跳到主要导航 跳到搜索 跳到主要内容

重症患者凝血酶原复合物合理应用中国专家共识

  • Chinese Society of Thrombosis, Hemostasis and Critical Care
  • , Chinese Medicine Education Association
  • , People's Liberation Army Professional Committee of Critical Care Medicine
  • , Chinese Society of Thrombosis and Hemostasis
  • , Chinese Research Hospital Association
  • The 908th Hospital of Joint Logistics Support Forces of Chinese PLA
  • The Second Affiliated Hospital of Xi'an Jiaotong University
  • Shandong Blood Center
  • The First Affiliated Hospital of Kunming Medical University
  • The First Affiliated Hospital of Jinan University
  • Fujian Provincial Maternity and Child Health Hospital
  • Nanjing General Hospital
  • China Medical University
  • Chinese Academy of Medical Sciences

科研成果: 期刊稿件文章同行评审

摘要

The prothrombin complex concentrate (PCC) is a blood product that mainly contains vitamin K-dependent coagulation factors. PCC has been used clinically for more than 70 years, and its safety has been significantly improved. It has been widely used in the treatment of coagulation disorders or severe bleeding in critically ill patients. If used improperly, it may weaken the hemostatic effect or increase the risk of thrombosis. In order to standardize the rational use of PCC, Chinese Society of Thrombosis, Hemostasis and Critical Care, Chinese Medicine Education Association, People's Liberation Army Professional Committee of Critical Care Medicine, Chinese Society of Thrombosis and Hemostasis, Chinese Research Hospital Association have organized the formulation of this expert consensus, including three parts: definition, indications, and monitoring and evaluation of efficacy, with a total of 10 suggestions, aiming to help clinicians reasonably use PCC and improve the treatment in critical illness.

投稿的翻译标题Chinese expert consensus on the rational use of prothrombin complex concentrate in critically ill patients
源语言繁体中文
页(从-至)1359-1369
页数11
期刊Medical Journal of Chinese People's Liberation Army
48
12
DOI
出版状态已出版 - 2023
已对外发布

关键词

  • blood coagulation factors
  • critical illness
  • hemorrhage
  • prothrombin complex concentrate

学术指纹

探究 '重症患者凝血酶原复合物合理应用中国专家共识' 的科研主题。它们共同构成独一无二的学术指纹。

引用此